Brainstorm Cell Therapeutics (BCLI) News Today $0.22 -0.08 (-26.49%) (As of 12/7/2023 ET) Add Compare Share Share Today's Range$0.22▼$0.2750-Day Range$0.15▼$0.4052-Week Range$0.13▼$3.46Volume6.01 million shsAverage Volume1.09 million shsMarket Capitalization$10.87 millionP/E RatioN/ADividend YieldN/APrice Target$10.00 HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineWhy BrainStorm Cell Therapeutics Shares Are Fallingmsn.com - December 7 at 7:08 PMBrainStorm Cell Therapeutics Announces Outcome of FDA Meeting on NurOwn® in ALSfinance.yahoo.com - December 7 at 9:06 AMBrainstorm Cell Therapeutics (NASDAQ:BCLI) Now Covered by Analysts at StockNews.comamericanbankingnews.com - December 6 at 1:28 AMBrainstorm Cell Therapeutics Inc BCLImorningstar.com - November 28 at 6:16 PMBrainstorm Cell Therapeutics (NASDAQ:BCLI) Research Coverage Started at StockNews.comamericanbankingnews.com - November 28 at 1:10 AMINVESTOR ALERT: Levi & Korsinsky Notifies Brainstorm Cell Therapeutics Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - BCLIbarrons.com - November 26 at 12:06 AMSHAREHOLDER ALERT: Levi & Korsinsky Notifies Brainstorm Cell Therapeutics Inc. Investors of a Class Action Lawsuit and Upcoming Deadline -- BCLIbarrons.com - November 23 at 11:55 PMBrainstorm Cell Therapeutics Inc. Class Action Reminder: Contact Robbins LLP for Information About the BCLI Class Actionbenzinga.com - November 21 at 9:10 PMBrainstorm Cell Therapeutics (NASDAQ:BCLI) to Meet with FDA for New Treatment Plansmsn.com - November 21 at 8:50 AMBCLI INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Brainstorm Cell Therapeutics Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!businesswire.com - November 20 at 3:06 PMSHAREHOLDER ALERT: Levi & Korsinsky Notifies Brainstorm Cell Therapeutics Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - BCLIbarrons.com - November 20 at 12:12 PMBrainStorm Cell Therapeutics: FDA Grants In-person Meeting To Discuss Best Path Forward For NurOwnmarkets.businessinsider.com - November 20 at 12:12 PMBrainStorm Cell Therapeutics Announces In-Person Meeting with the FDA to Discuss Confirmatory Phase 3 Trial for NurOwn® in ALSfinance.yahoo.com - November 20 at 12:12 PMBrainStorm Cell Therapeutics to Present at 6th Annual ALS Research Symposiafinance.yahoo.com - November 17 at 7:10 AMGlancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Brainstorm Cell Therapeutics Inc. (BCLI)benzinga.com - November 16 at 8:18 PMBCLI: Phase 3b Trial Details to be Discussed with FDA…finance.yahoo.com - November 16 at 3:11 PMBrainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) Q3 2023 Earnings Call Transcriptfinance.yahoo.com - November 15 at 6:16 PMQ3 2023 Brainstorm Cell Therapeutics Inc Earnings Callfinance.yahoo.com - November 15 at 8:11 AMBrainStorm Cell Therapeutics Inc.: BrainStorm Cell Therapeutics Announces Third quarter 2023 Financial Results and Provides Corporate Updatefinanznachrichten.de - November 14 at 9:27 AMBrainStorm Cell Therapeutics Announces Third quarter 2023 Financial Results and Provides Corporate Updatefinance.yahoo.com - November 14 at 9:27 AMBrainstorm Cell Therapeutics Inc. (BCLI) Investors: Shareholders with Large Losses Should Contact Robbins LLP Regarding the BCLI Class Actionbusinesswire.com - November 14 at 12:21 AMSHAREHOLDER ALERT: Levi & Korsinsky Notifies Brainstorm Cell Therapeutics Inc.(BCLI) Investors of a Class Action Lawsuit and Upcoming Deadlinebenzinga.com - November 9 at 5:33 PMGlancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces the Filing of a Securities Class Action on Behalf of Brainstorm Cell Therapeutics Inc. (BCLI) Investorsbusinesswire.com - November 8 at 9:15 PMThe Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Brainstorm Cell Therapeutics Inc. (BCLI) Investorsbenzinga.com - November 7 at 12:46 PMBrainStorm to Announce Third Quarter 2023 Financial Results and Provide a Corporate Updatefinance.yahoo.com - November 7 at 7:35 AMINVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Brainstorm Cell Therapeutics Inc. (BCLI) on Behalf of Investorstmcnet.com - November 6 at 3:57 PMSHAREHOLDER ALERT: Levi & Korsinsky Notifies Brainstorm Cell Therapeutics Inc. (BCLI) Investors of a Class Action Lawsuit and Upcoming Deadlinebenzinga.com - November 6 at 3:57 PMBrainstorm Cell Therapeutics Inc. (BCS) Investor Notice: Robbins LLP Reminds Investors of Class Action Against Brainstorm Cell Therapeutics Inc.stockhouse.com - November 6 at 3:57 PMThe Law Offices of Frank R. Cruz Announces Investigation of Brainstorm Cell Therapeutics Inc. (BCLI) on Behalf of Investorsbusinesswire.com - November 3 at 11:40 PMShareholder Alert: Robbins LLP Informs Shareholders of Class Action Filed Against Brainstorm Cell Therapeutics Inc. (BCS)benzinga.com - November 3 at 6:40 PMGainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Brainstorm Cell Therapeutics Inc. (BCLI)benzinga.com - November 2 at 7:53 PMEQUITY ALERT: Rosen Law Firm Files Securities Class Action Lawsuit Against Brainstorm Cell Therapeutics Inc. – BCLIbusinesswire.com - November 1 at 11:43 PMBrainStorm Cell Therapeutics Announces Strategic Realignment Prioritizing NurOwn® for the Treatment of ALSfinance.yahoo.com - October 24 at 8:32 AMBCLI: Meeting with FDA to Discuss Development Plan for NurOwn®…finance.yahoo.com - October 23 at 3:36 PMBrainStorm Cell Therapeutics to Meet with US FDA to Discuss Development Plan for NurOwn as a Treatment of ALSfinance.yahoo.com - October 18 at 8:01 AMROSEN, GLOBAL INVESTOR COUNSEL, Encourages Brainstorm Cell Therapeutics Inc. Investors to Inquire About Securities Class Action Investigation - BCLIstockhouse.com - October 9 at 9:38 AMROSEN, A TOP RANKED LAW FIRM, Encourages Brainstorm Cell Therapeutics Inc. Investors to Inquire About Securities Class Action Investigation - BCLIbenzinga.com - October 7 at 2:53 PMBCLI: Advisory Panel Votes Against Recommending Approval of NurOwn®…finance.yahoo.com - October 2 at 3:06 PMBrainStorm shares plunge 56% after FDA advisers reject ALS cell therapyproactiveinvestors.com - September 28 at 6:15 PMBrainStorm shares plunge 56% after FDA advisors reject ALS cell therapyproactiveinvestors.com - September 28 at 6:15 PMROSEN, TRUSTED INVESTOR COUNSEL, Encourages Brainstorm Cell Therapeutics Inc. Investors to Inquire About Securities Class Action Investigation - BCLItmcnet.com - September 28 at 6:15 PMFDA panel rejects ALS treatment from Brainstorm Cell Therapeuticsmsn.com - September 28 at 8:15 AMBrainStorm Cell Therapeutics Provides Update on FDA Advisory Committee Meeting to Review NurOwn for the Treatment of ALSfinance.yahoo.com - September 28 at 12:46 AMFDA advisers vote against experimental ALS treatment pushed by patientsfinance.yahoo.com - September 27 at 7:46 PMBrainStorm Cell Therapeutics Inc.: BrainStorm Cell Therapeutics Stock Trading Halted Todayfinanznachrichten.de - September 27 at 9:44 AMBrainStorm Cell Therapeutics Stock Trading Halted Todayfinance.yahoo.com - September 27 at 9:44 AMmarketbeat.com - September 27 at 6:58 AMBCLI: Public Support for NurOwn® from Prominent ALS Specialists…finance.yahoo.com - September 26 at 6:43 PMBrainStorm Cell plummets after FDA raises doubts over ALS therapyproactiveinvestors.com - September 25 at 2:19 PMWhy Is Neurodegenerative Disease-Focused Brainstorm Cell Therapeutics Stock Plunging Today?msn.com - September 25 at 2:19 PM Get Brainstorm Cell Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for BCLI and its competitors with MarketBeat's FREE daily newsletter. Email Address BCLI Media Mentions By Week BCLI Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BCLI News Sentiment▼0.000.51▲Average Medical News Sentiment BCLI News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BCLI Articles This Week▼31▲BCLI Articles Average Week Get Brainstorm Cell Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for BCLI and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: ONVO News Today SQZ News Today ACOR News Today GENE News Today SRZN News Today EIGR News Today BCDA News Today FNCH News Today ALBT News Today SNTI News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat Originals This page (NASDAQ:BCLI) was last updated on 12/8/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Brainstorm Cell Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.